Who We Are

Who We Are

Founded in July 2018, JLABS@TMC resident Skipper Bio Med LLC is a charitable research consultancy that provides services to preclinical research groups developing promising lung or pancreatic cancer technologies. Skipper is funded by a US family that is determined to improve patient outcomes and our focus is to benefit patients by ensuring our clients can cross the research valleys of death.

Competitive Advantage

We are the only providers of charitable strategy consulting for preclinical lung and pancreatic cancer researchers. Positioned in the Texas Medical Center, we have direct access to a large and diverse population of biomedical key opinion leaders and resources. With our patient-centric mindset, Skipper does not seek compensation of any kind (monetary, equity, IP etc) from our clients. We are in a unique position to leverage resources and partnerships from academia, industry and third-party organizations to give clients the personalized tools they need to translate their technologies into clinical practice.

Meet Our Team

Paul A. Kurywchak, PhD

Executive Director

Paul manages overall operations, leads all client and partner relationships, and makes major decisions for Skipper’s direction. He also develops client engagement strategies by prioritizing and delegating tasks among team members. Paul received his PhD in Cancer Biology from the MD Anderson Cancer Center – UTHealth Graduate School of Biomedical Sciences, where he studied exosome biology and their biomarker potential in the laboratory of Dr. Raghu Kalluri.

Sanjana Mahapatra, PhD

Strategy Director

Sanjana evaluates the regulatory, IP, and funding status of client technologies and develops tailored strategies to navigate their specific challenges towards commercialization. She also initiates partnerships with academic tech transfer offices (TTOs), investors, other consultancies, and service providers. Sanjana received her PhD in Immunology from Baylor College of Medicine, where she studied the phenotype of natural killer cells in healthy children and pediatric HIV under the co-mentorship of Dr. Jordan Orange and Dr. William Shearer.

Dustin Srinivas, PhD

Research Director

Dustin’s focus is to leverage his expertise in cancer therapeutics to evaluate the quality and research potential of client technologies. Dustin engages directly with clients by assisting them with the development of research marketing materials and partnering opportunities. Dustin received his PhD in Biomedical Sciences and Translational Medicine from Cedars Sinai Medical Center, where he studied the delivery of cancer therapeutics via nanoscale receptor-targeting vehicles in the laboratory of Dr. Lali Medina-Kauwe.

Terry McNearney, MD

Senior Consultant

Terry is Board Certified in Internal Medicine and Rheumatology. She performed basic and clinical research, and supervised patient clinics for 16 years at the UTMB in Galveston, TX. She recently spent 7 years as a Senior Medical Advisor in a Neuroscience/Pain Early Program at Eli Lilly. She has also served as a pancreatic and lung cancers program and grant reviewer, as well as a consultant to foundations for over 10 years.